Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Waight

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Vaccine|November 11, 2006
Similar long-term vaccine efficacy of two versus three doses of HBV vaccine in early lifeM A B van der Sande, M Mendy, P Waight, et al.
BMJ (Clinical Research Ed.)|February 13, 1993
Sexually transmitted diseases and HIV-1 infection among homosexual men in England and WalesB G Evans, M A Catchpole, J Heptonstall, et al.
Public Health|March 1, 1989
Chronic liver disease. A case control study of the effect of previous blood transfusionG M Wood, L J Levy, M S Losowsky, et al.
Epidemiology and Infection|October 27, 2007
Trends in incidence of pneumococcal disease before introduction of conjugate vaccine: South West England, 1996-2005C A Ihekweazu, D A B Dance, R Pebody, et al.
The Journal of Infectious Diseases|December 20, 2000
Invasive pneumococcal disease in England and Wales: vaccination implicationsK Sleeman, K Knox, R George, et al.
The Journal of Infectious Diseases|May 3, 2006
Long-term protection against carriage of hepatitis B virus after infant vaccinationM A B van der Sande, P Waight, M Mendy, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|May 28, 2010
Pandemic Influenza A (H1N1) 2009 and mortality in the United Kingdom: risk factors for death, April 2009 to March 2010R G Pebody, E McLean, H Zhao, et al.
Health Technology Assessment (Winchester, England)|October 7, 2010
Open-label, randomised, parallel-group, multicentre study to evaluate the safety, tolerability and immunogenicity of an AS03(B)/oil-in-water emulsion-adjuvanted (AS03(B)) split-virion versus non-adjuvanted whole-virion H1N1 influenza vaccine in UK children 6 months to 12 years of ageCs Waddington, N Andrews, K Hoschler, et al.
BMJ (Clinical Research Ed.)|May 29, 2010
Safety and immunogenicity of AS03B adjuvanted split virion versus non-adjuvanted whole virion H1N1 influenza vaccine in UK children aged 6 months-12 years: open label, randomised, parallel group, multicentre studyClaire S Waddington, W T Walker, C Oeser, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Vaccine|November 11, 2006
Similar long-term vaccine efficacy of two versus three doses of HBV vaccine in early lifeM A B van der Sande, M Mendy, P Waight, et al.
BMJ (Clinical Research Ed.)|February 13, 1993
Sexually transmitted diseases and HIV-1 infection among homosexual men in England and WalesB G Evans, M A Catchpole, J Heptonstall, et al.
Public Health|March 1, 1989
Chronic liver disease. A case control study of the effect of previous blood transfusionG M Wood, L J Levy, M S Losowsky, et al.
Epidemiology and Infection|October 27, 2007
Trends in incidence of pneumococcal disease before introduction of conjugate vaccine: South West England, 1996-2005C A Ihekweazu, D A B Dance, R Pebody, et al.
The Journal of Infectious Diseases|December 20, 2000
Invasive pneumococcal disease in England and Wales: vaccination implicationsK Sleeman, K Knox, R George, et al.
The Journal of Infectious Diseases|May 3, 2006
Long-term protection against carriage of hepatitis B virus after infant vaccinationM A B van der Sande, P Waight, M Mendy, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|May 28, 2010
Pandemic Influenza A (H1N1) 2009 and mortality in the United Kingdom: risk factors for death, April 2009 to March 2010R G Pebody, E McLean, H Zhao, et al.
Health Technology Assessment (Winchester, England)|October 7, 2010
Open-label, randomised, parallel-group, multicentre study to evaluate the safety, tolerability and immunogenicity of an AS03(B)/oil-in-water emulsion-adjuvanted (AS03(B)) split-virion versus non-adjuvanted whole-virion H1N1 influenza vaccine in UK children 6 months to 12 years of ageCs Waddington, N Andrews, K Hoschler, et al.
BMJ (Clinical Research Ed.)|May 29, 2010
Safety and immunogenicity of AS03B adjuvanted split virion versus non-adjuvanted whole virion H1N1 influenza vaccine in UK children aged 6 months-12 years: open label, randomised, parallel group, multicentre studyClaire S Waddington, W T Walker, C Oeser, et al.
Pageof 3